Market Cap 592.57M
Revenue (ttm) 18.14M
Net Income (ttm) -72.85M
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin N/A
Debt to Equity Ratio N/A
Volume 649,900
Avg Vol 936,122
Day's Range N/A - N/A
Shares Out 188.72M
Stochastic %K 2%
Beta 1.98
Analysts Strong Sell
Price Target $4.50

Company Profile

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reaw...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 469 0914
Address:
701 Veterans Circle, Warminster, United States
Heavey
Heavey Jul. 15 at 10:27 PM
$ABUS not getting excited over a 10 share trade
0 · Reply
Aswizz
Aswizz Jul. 15 at 9:01 PM
$ABUS uh oh somebody got some news!!!
1 · Reply
Buqqets
Buqqets Jul. 15 at 7:10 PM
0 · Reply
countingguy2006
countingguy2006 Jul. 15 at 5:04 PM
$ABUS No affirmation on the $180 million that they were supposed to receive last week, no updates from the IR Department of ABUS about that. Shoild be no secret because it was settled more that 4 months ago! The silence is deafening! If we had a reasonable chance of winning a class action lawsuit, I would be all in on that! Whiteford Capital is effectively an insider not an activist investor like we believed before. They have been complicit in the last 6 to 8 months allowing the officers of ABUS to do whatever and not a word from them. Makes us question our choice of investing in a company who has IP and potential, but is run by silence and greed from insiders, hedges, tutes, a lame BOD and officers!
2 · Reply
Grtgooglymoogly
Grtgooglymoogly Jul. 15 at 4:56 PM
$ABUS I still think some knew something was up a few days before the judge wrote the order for the july 17th conference. The volume increased (5 million plus days started a few days BEFORE) There has been no news. Its the only thing that makes sense. Not the moderna payment
0 · Reply
MyBrokenBus
MyBrokenBus Jul. 15 at 4:15 PM
$ABUS up a buck, down a buck; the tale of two weeks. Hopefully, one day, someone lets us know what exactly everybody is buying and selling around here.
2 · Reply
Buqqets
Buqqets Jul. 15 at 3:51 PM
0 · Reply
Onethousand1
Onethousand1 Jul. 15 at 3:38 PM
$ABUS I hope everyone's feeling lucky for the next few weeks!
0 · Reply
trout290zzaam
trout290zzaam Jul. 15 at 2:38 PM
$ABUS Buyouts are very rarely announced at the highs. Not suggesting that’s what’s happening but I wouldn’t expect a huge run up beforehand either.
1 · Reply
countingguy2006
countingguy2006 Jul. 15 at 2:14 PM
$ABUS All of this guessing and prediction and speculation is just that. It doesn't move the needle and have created more "bagholders" in the long term unless they have swing traded the stock. This stock doesn't move up according to predictable events.Many of us have effectively wasted years of potential return with other securities in the biomed field that had better returns including MRNA that ran from $THE20 to almost $500 at one time.ABUSs criminal insiders know when the events will happen and just like last time the stock can move before or after events, but rarely on scheduled dates because of the secrecy of the Investor relations "team", BOD and past CEOs.When their insiders and institutions own 95% of the stock, individual stockholders can only hope of an increase and then as we all can see the increase is short lived and never has been able to keep support in the price levels like the 20s or 30s that ABUS's LPN IP portfoliop and HEP B fair value should be in the stock's price.
0 · Reply
Latest News on ABUS
Arbutus Biopharma Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 2 months ago

Arbutus Biopharma Quarterly report: Q1 2026


Arbutus Biopharma Earnings release: Q1 2026

May 13, 2026, 7:00 AM EDT - 2 months ago

Arbutus Biopharma Earnings release: Q1 2026


Arbutus Biopharma granted Fast Track designation for imdusiran

2026-04-15T11:35:22.000Z - 3 months ago

Arbutus Biopharma granted Fast Track designation for imdusiran


Arbutus Biopharma Proxy statement: Proxy filing

Apr 14, 2026, 8:00 AM EDT - 3 months ago

Arbutus Biopharma Proxy statement: Proxy filing


Arbutus Biopharma Proxy statement: Proxy filing

Apr 14, 2026, 8:00 AM EDT - 3 months ago

Arbutus Biopharma Proxy statement: Proxy filing


Arbutus Biopharma Earnings release: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 4 months ago

Arbutus Biopharma Earnings release: Q4 2025


Arbutus Biopharma Annual report: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 4 months ago

Arbutus Biopharma Annual report: Q4 2025


Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

2026-03-04T16:55:47.000Z - 4 months ago

Why Is Moderna (MRNA) Stock Surging Today, 3/4/26?

MRNA


Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)

2025-11-13T12:41:19.000Z - 8 months ago

Arbutus Biopharma reports Q3 EPS (4c), consensus (5c)


Arbutus Biopharma Earnings release: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

Arbutus Biopharma Earnings release: Q3 2025


Arbutus Biopharma Quarterly report: Q3 2025

Nov 13, 2025, 7:00 AM EST - 8 months ago

Arbutus Biopharma Quarterly report: Q3 2025


Arbutus Biopharma Earnings release: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Arbutus Biopharma Earnings release: Q2 2025


Arbutus Biopharma Quarterly report: Q2 2025

Aug 6, 2025, 4:00 PM EDT - 1 year ago

Arbutus Biopharma Quarterly report: Q2 2025


Arbutus Biopharma Quarterly report: Q1 2025

May 14, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Quarterly report: Q1 2025


Arbutus Biopharma Earnings release: Q1 2025

May 14, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Earnings release: Q1 2025


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Earnings release: Q4 2024

Mar 27, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Earnings release: Q4 2024


Arbutus Biopharma Annual report: Q4 2024

Mar 27, 2025, 7:30 AM EDT - 1 year ago

Arbutus Biopharma Annual report: Q4 2024


Arbutus Provides 2025 Corporate and Financial Update

Jan 13, 2025, 7:30 AM EST - 1 year ago

Arbutus Provides 2025 Corporate and Financial Update


Arbutus Biopharma Transcript: Status Update

Dec 3, 2024, 11:00 AM EST - 1 year ago

Arbutus Biopharma Transcript: Status Update


Arbutus to Present at Jefferies London Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Arbutus to Present at Jefferies London Healthcare Conference


Arbutus Biopharma Earnings Call Transcript: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Earnings Call Transcript: Q3 2024


Arbutus Biopharma Quarterly report: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Quarterly report: Q3 2024


Arbutus Biopharma Earnings release: Q3 2024

Nov 6, 2024, 8:45 AM EST - 1 year ago

Arbutus Biopharma Earnings release: Q3 2024


Arbutus to Participate in Two Upcoming Investor Conferences

Sep 3, 2024, 7:30 AM EDT - 2 years ago

Arbutus to Participate in Two Upcoming Investor Conferences


Arbutus Biopharma Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q2 2024


Arbutus Biopharma Quarterly report: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Quarterly report: Q2 2024


Arbutus Biopharma Earnings release: Q2 2024

Aug 1, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings release: Q2 2024


Arbutus Distributors Ltd. News Release

Jun 3, 2024, 9:50 AM EDT - 2 years ago

Arbutus Distributors Ltd. News Release


Arbutus to Present Imdusiran Data at EASL Congress 2024

May 22, 2024, 2:00 AM EDT - 2 years ago

Arbutus to Present Imdusiran Data at EASL Congress 2024


Arbutus Biopharma Earnings Call Transcript: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q1 2024


Arbutus Biopharma Quarterly report: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Quarterly report: Q1 2024


Arbutus Biopharma Earnings release: Q1 2024

May 2, 2024, 8:45 AM EDT - 2 years ago

Arbutus Biopharma Earnings release: Q1 2024


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Proxy statement: Proxy Filing

Apr 10, 2024, 8:00 AM EDT - 2 years ago

Arbutus Biopharma Proxy statement: Proxy Filing


Arbutus Biopharma Earnings Call Transcript: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q4 2023


Arbutus Biopharma Annual report: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Annual report: Q4 2023


Arbutus Biopharma Earnings release: Q4 2023

Feb 29, 2024, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings release: Q4 2023


Arbutus Biopharma Slides: Corporate Presentation

Nov 9, 2023, 7:00 AM EST - 2 years ago

Arbutus Biopharma Slides: Corporate Presentation


Arbutus Biopharma Earnings Call Transcript: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings Call Transcript: Q3 2023


Arbutus Biopharma Quarterly report: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Quarterly report: Q3 2023


Arbutus Biopharma Earnings release: Q3 2023

Nov 7, 2023, 8:45 AM EST - 2 years ago

Arbutus Biopharma Earnings release: Q3 2023


Arbutus Biopharma Earnings Call Transcript: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Earnings Call Transcript: Q2 2023


Arbutus Biopharma Quarterly report: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Quarterly report: Q2 2023


Arbutus Biopharma Earnings release: Q2 2023

Aug 3, 2023, 8:45 AM EDT - 3 years ago

Arbutus Biopharma Earnings release: Q2 2023


Heavey
Heavey Jul. 15 at 10:27 PM
$ABUS not getting excited over a 10 share trade
0 · Reply
Aswizz
Aswizz Jul. 15 at 9:01 PM
$ABUS uh oh somebody got some news!!!
1 · Reply
Buqqets
Buqqets Jul. 15 at 7:10 PM
0 · Reply
countingguy2006
countingguy2006 Jul. 15 at 5:04 PM
$ABUS No affirmation on the $180 million that they were supposed to receive last week, no updates from the IR Department of ABUS about that. Shoild be no secret because it was settled more that 4 months ago! The silence is deafening! If we had a reasonable chance of winning a class action lawsuit, I would be all in on that! Whiteford Capital is effectively an insider not an activist investor like we believed before. They have been complicit in the last 6 to 8 months allowing the officers of ABUS to do whatever and not a word from them. Makes us question our choice of investing in a company who has IP and potential, but is run by silence and greed from insiders, hedges, tutes, a lame BOD and officers!
2 · Reply
Grtgooglymoogly
Grtgooglymoogly Jul. 15 at 4:56 PM
$ABUS I still think some knew something was up a few days before the judge wrote the order for the july 17th conference. The volume increased (5 million plus days started a few days BEFORE) There has been no news. Its the only thing that makes sense. Not the moderna payment
0 · Reply
MyBrokenBus
MyBrokenBus Jul. 15 at 4:15 PM
$ABUS up a buck, down a buck; the tale of two weeks. Hopefully, one day, someone lets us know what exactly everybody is buying and selling around here.
2 · Reply
Buqqets
Buqqets Jul. 15 at 3:51 PM
0 · Reply
Onethousand1
Onethousand1 Jul. 15 at 3:38 PM
$ABUS I hope everyone's feeling lucky for the next few weeks!
0 · Reply
trout290zzaam
trout290zzaam Jul. 15 at 2:38 PM
$ABUS Buyouts are very rarely announced at the highs. Not suggesting that’s what’s happening but I wouldn’t expect a huge run up beforehand either.
1 · Reply
countingguy2006
countingguy2006 Jul. 15 at 2:14 PM
$ABUS All of this guessing and prediction and speculation is just that. It doesn't move the needle and have created more "bagholders" in the long term unless they have swing traded the stock. This stock doesn't move up according to predictable events.Many of us have effectively wasted years of potential return with other securities in the biomed field that had better returns including MRNA that ran from $THE20 to almost $500 at one time.ABUSs criminal insiders know when the events will happen and just like last time the stock can move before or after events, but rarely on scheduled dates because of the secrecy of the Investor relations "team", BOD and past CEOs.When their insiders and institutions own 95% of the stock, individual stockholders can only hope of an increase and then as we all can see the increase is short lived and never has been able to keep support in the price levels like the 20s or 30s that ABUS's LPN IP portfoliop and HEP B fair value should be in the stock's price.
0 · Reply
Thalassophile
Thalassophile Jul. 15 at 1:59 PM
$ABUS Straight up larceny
1 · Reply
LM_Johanssen
LM_Johanssen Jul. 15 at 1:58 PM
$ABUS Arbutus should use the settlement money to begin development of a novel treatment for blue balls. The drug marketing will practically take care of itself as they already have the names and addresses of afflicted shareholders.
1 · Reply
FatedFish
FatedFish Jul. 15 at 1:54 PM
$ABUS Odds are no halt this week, meeting at 1130am Friday, terms finalized, silence, Sunday there's a PR in the evening or afternoon. Monday opens to a gap up.
0 · Reply
renoH4
renoH4 Jul. 15 at 12:54 PM
$ABUS ..However, trading in Arbutus shares could be suspended as early as the market open on Friday. That would make Thursday the last chance to get in.
1 · Reply
renoH4
renoH4 Jul. 15 at 12:35 PM
$ABUS ..Ride the storm until friday and enjoy sunrise on monday. May be we get the News friday after hours - hold and buy imo
0 · Reply
punktdot
punktdot Jul. 15 at 10:32 AM
$ABUS I honestly got excited for a bit there, back to the normal channel again it seems :(
0 · Reply
Joe_Mama
Joe_Mama Jul. 14 at 9:08 PM
$ABUS Next we bounce off the right side and go up.
3 · Reply
SpaceCityKid
SpaceCityKid Jul. 14 at 8:43 PM
$ABUS Hammer reversal off the 50 day. A good sign, but volume really didn't show conviction. Tomorrow will be key.
0 · Reply
GABIRODZ01
GABIRODZ01 Jul. 14 at 8:37 PM
$ABUS I just hope… HOPE!!!!… that on 07/17/2026, once we get some good news regarding (maybe possible $PFE settlement hints), dividend possible payment… whatever possitive news…. That at leaat, the stock moves upwards. I just don’t want to imagine the the stock will ONLY move upwards once we have a commercialized HBV treatment. That is going to take even more years to get finalized, (if it happens)
0 · Reply
renoH4
renoH4 Jul. 14 at 5:28 PM
0 · Reply
Alfalcon
Alfalcon Jul. 14 at 2:53 PM
2 · Reply
FatedFish
FatedFish Jul. 14 at 2:48 PM
$ABUS Odds of settlement this weekend?
2 · Reply